Insilico Medicine launched Nach01, a multimodal foundation AI model on AWS Marketplace designed to accelerate generative chemistry for drug design. This large language model integrated with spatial chemical data enhances molecular prediction and retrosynthesis capabilities with scalable cloud infrastructure. Nach01 aims to transform pharmaceutical research workflows by enabling rapid and accurate molecular synthesis, potentially shortening drug development timelines across academic and industrial settings.